ME Therapeutics Holdings Inc.

Research ME Therapeutics Holdings Inc. (Q9T) on Bullrun: market cap EUR 25.84M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerQ9T
• ExchangeF
• CountryCanada
• SectorHealthcare
• IndustryBiotechnology
• CurrencyEUR
• Market capEUR 25.84M
• Financial periodQ1 2026
• Net income-EUR 289.23K
• Free cash flow-EUR 372.49K

Valuation Snapshot

latest market cap is EUR 25.84M.

About ME Therapeutics Holdings Inc.

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. The company's lead candidate, h1B11-12, is a glycoprotein cytokine antibody drug that targets a key protein involved in the generation of suppressive myeloid cells for the treatment of colorectal cancer. It also develops D094 and D099, which are small molecule myeloid targeted prodrug candidates to treat cancer;

Frequently asked questions

What is ME Therapeutics Holdings Inc.'s market cap?

ME Therapeutics Holdings Inc.'s market capitalization is EUR 25.84M.

What does ME Therapeutics Holdings Inc. do?

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology.